Wedbush Starts Acer Therapeutics (ACER) at Outperform
Tweet
Share
E-mailGet Alerts ACER Hot Sheet
Price: $0.90 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Wedbush analyst Laura Chico initiates coverage on Acer Therapeutics (NASDAQ: ACER) with a Outperform rating and a price target of $48.00.
For an analyst ratings summary and ratings history on Acer Therapeutics click here. For more ratings news on Acer Therapeutics click here.
Shares of Acer Therapeutics closed at $19.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
- Bernstein SocGen Group Starts Cipher Mining (CIFR) at Outperform
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
